Document Type
Brief
Publication Date
2015
Abstract
The progesterone vaginal ring (PVR) is a safe and effective method of contraception for lactating women. It is a priority medicine on the WHO’s Essential Medicines List and is included in the Medical Eligibility Criteria for family planning providers. Developed by the Population Council, the PVR is an intravaginal ring that provides women who breastfeed at least four times a day with a contraceptive option as early as four weeks after giving birth. The PVR provides a new option to reduce unmet need among new mothers, allow women to safely space their pregnancies, and improve the health of women and children around the world. This fact sheet serves as a call-to-action to fill critical gaps in postpartum family planning.
Recommended Citation
"Progesterone vaginal ring: A call-to-action to fill critical gaps in post-partum family planning," Advocacy brief. New York: Population Council, 2015.
DOI
10.31899/rh9.1061
Language
English
Project
The Progesterone Contraceptive Vaginal Ring: Expanding Contraceptive Options in Africa
Included in
Demography, Population, and Ecology Commons, Family, Life Course, and Society Commons, International Public Health Commons, Women's Health Commons